本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tarsus Pharmaceuticals, Inc.

78.62
+0.39000.50%
成交量:5.11萬
成交額:401.80萬
市值:34.50億
市盈率:-72.63
高:79.10
開:78.43
低:78.15
收:78.23
52周最高:91.53
52周最低:48.76
股本:4,388.30萬
流通股本:3,563.83萬
量比:0.97
換手率:0.14%
股息:- -
股息率:- -
每股收益(TTM):-1.0824
每股收益(LYR):-1.5900
淨資產收益率:-13.68%
總資產收益率:-5.48%
市淨率:9.95
市盈率(LYR):-49.45

資料載入中...

2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/11

重要事件披露

Form 8-K - Current report
2026/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/13

重要事件披露

Form 8-K - Current report